Compare FATE & AMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FATE | AMCI |
|---|---|---|
| Founded | 2007 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.6M | 110.5M |
| IPO Year | 2013 | 2022 |
| Metric | FATE | AMCI |
|---|---|---|
| Price | $2.58 | $4.74 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.10 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 151.1K |
| Earning Date | 05-14-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.88 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $6,646,000.00 | $5,980,847.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $481.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.93 | $3.60 |
| 52 Week High | $3.23 | $15.75 |
| Indicator | FATE | AMCI |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 49.03 |
| Support Level | $1.01 | $4.09 |
| Resistance Level | $2.88 | $5.81 |
| Average True Range (ATR) | 0.19 | 0.51 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 48.41 | 32.58 |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
AMC Robotics Corp is a technology solutions company that offers AI-powered smart security and robotics solutions. It currently sells smart hardware products designed for residential and commercial use, including smart cameras, driving recorders, action cameras, and Retina K cameras, which are marketed under the YI brand. AMC Robotics is also engaged in developing additional hardware products and technology capabilities, including IoT-enabled devices, AI-based features, wearable devices, and AI robotics. Using its technological capabilities, the company is developing robotic dogs, robotic arms, and robotic unloading systems, offering smart solutions for the logistics and warehousing sectors. It has two primary operating segments: North America, which generates maximum revenue, and Europe.